Diabetes Mellitus: The Biochemical Pathways of Oxidative Stress

Background: Diabetes mellitus (DM) is a leading global cause of morbidity and mortality. Persistent hyperglycemia drives micro- and macrovascular injury through oxidative stress (OS), wherein reactive oxygen/nitrogen species (ROS/RNS) overwhelm antioxidant defenses, damaging lipids, proteins, and DNA.Aim: To synthesize current mechanistic understanding of how hyperglycemia induces OS in DM, mapping the principal biochemical pathways, their clinical sequelae, and therapeutic implications.Methods: Narrative, mechanism-focused integration of evidence spanning mitochondrial biology, redox biochemistry, and vascular/neuronal pathology, emphasizing canonical glucose-driven routes (polyol, AGEs/RAGE, PKC/DAG, hexosamine) and upstream GAPDH inhibition. Biomarker and tissue-level findings are aligned with clinical complications.Results: Mitochondrial over-reduction elevates superoxide and activates PARP-1, inhibiting GAPDH and diverting triose phosphates into four maladaptive pathways: (i) Polyol flux depletes NADPH, uncouples eNOS, and increases ROS; (ii) AGE formation and RAGE signaling stiffen matrices and activate NOX/NF-κB; (iii) PKC activation (via DAG) enhances vasoconstriction, permeability, inflammation, and NOX-derived ROS; (iv) Hexosamine pathway augments O-GlcNAcylation, promoting profibrotic transcription. These interlocked circuits lower NO bioavailability, foster peroxynitrite formation, and propagate endothelial dysfunction. Biomarkers (F2-isoprostanes, 8-oxo-dG, nitrotyrosine, protein carbonyls) correlate with retinopathy, nephropathy, neuropathy, and atherosclerosis. Targeted strategies—aldose-reductase inhibition, dicarbonyl trapping, PKC-β blockade, Nrf2 activation, mitochondria-directed antioxidants, and lifestyle interventions—seek to restore redox homeostasis rather than indiscriminately scavenge ROS.Conclusion: Oxidative distress is the central biochemical engine linking hyperglycemia to diabetic tissue injury. Precision modulation of source pathways and restoration of NO/GSH systems are required to interrupt progression from metabolic dysregulation to organ failure.